Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis

NCT02922192 is registered in ClinicalTrials.gov with Biologics & Biosimilars Collective Intelligence Consortium as lead sponsor.

NCT NCT02922192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02922192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis
Lead sponsor
Biologics & Biosimilars Collective Intelligence Consortium
Phase
Observational
Overall status
Completed
Start date
January 1, 2012
Completion date
June 1, 2020
Enrollment
90,360 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, inflammatory bowel disease, psoriasis, psoriatic arthritis, rheumatoid arthritis